Multicenter, Randomized Study Comparing Oral Valganciclovir Versus Intravenous Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation.
Phase of Trial: Phase III
Latest Information Update: 16 Dec 2013
At a glance
- Drugs Valganciclovir (Primary) ; Ganciclovir
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms CONVINCE
- 31 Mar 2012 Inclusion and exclusion criteria amended as reported by European Clinical Trials Database record.
- 23 Mar 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 14 Jun 2011 Additional locations (Austria,Germany, Spain) added as reported by ClinicalTrials.gov.